Arm workouts may boost heart function after spinal cord injury — a trial puts it to the test

NCT ID NCT07725952

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether an 8-week upper-limb resistance training program can improve cardiovascular autonomic function in adults with chronic spinal cord injury. Participants are randomly assigned to either supervised arm exercises three times per week or a control group. Researchers will measure heart rate variability, baroreflex sensitivity, blood pressure changes, and quality of life to see if strength training helps regulate heart function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a supervised upper-limb resistance training program
What this could lead to
If it works, this could point toward a simple exercise program to improve cardiovascular health and reduce dizziness in people with spinal cord injury.
What could go wrong
This is a small, early-stage trial with only 20 participants, so results may not apply widely. The training requires consistent effort, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypotension, Orthostatic spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Pusan National University Yangsan Hospital

    Yangsan, Gyeongsangnam-do, 50612, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.